Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
Response Assessment in SB CD

The small bowel (SB) is involved in ~70% of patients with Crohn's disease (CD). There is an unmet need for accurate and clinically meaningful methods to measure small bowel Crohn's Disease (SBCD) activity. This is particularly relevant as the field moves towards "treat-to-target" management strategies. The overall objective of this …

  • 13 views
  • 21 Mar, 2022
  • 1 location
Prediction Model for Response to Biologics and Small Molecular Agent for UC

This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.

vedolizumab
  • 0 views
  • 23 Mar, 2022
  • 1 location
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany

This study on biologics (Vedolizumab/anti-TNF) in the treatment of inflammatory bowel disease (IBD) patients in Germany extends the prospective documentation of efficacy in induction and

vedolizumab
enteropathy
tumor necrosis factor
tumor necrosis factor alpha
  • 4 views
  • 21 Jan, 2021
  • 1 location
A Study of Vedolizumab in Adults in Real-World Practice

Vedolizumab is a medicine that is currently prescribed for adults with moderately to severely active ulcerative colitis or Crohn's disease. In this study, adults with ulcerative colitis

ulcerative colitis
vedolizumab
crohn's disease
colitis
ulcerative colitis or crohn's
  • 0 views
  • 05 Dec, 2021
  • 42 locations
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

The purpose of this survey is to evaluate the long-term safety and effectiveness of vedolizumab for intravenous (IV) infusion 300 milligrams (mg) in ulcerative colitis (UC) patients in the

vedolizumab
  • 1 views
  • 11 May, 2022
  • 1 location
A Study of Vedolizumab in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease

In this study, participants with ulcerative colitis or Crohn's disease will be treated with vedolizumab according to their clinic's standard practice. The main aim of the study is to

ulcerative colitis
conventional treatment
crohn's disease
vedolizumab
colitis
  • 0 views
  • 29 May, 2022
  • 40 locations
A Study of Real-World Outcomes of People With Crohn's Disease (CD) (EVOLVE)

The main aim of this study is to compare long-term remission in participants receiving vedolizumab (VDZ) and those receiving ustekinumab (UST). In this study, the study doctors will

ustekinumab
vedolizumab
crohn's disease
remission
  • 0 views
  • 16 Jun, 2022
  • 23 locations
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

The purpose of this survey is to evaluate the long-term safety and effectiveness of vedolizumab for intravenous (IV) infusion 300 milligrams (mg) in Crohn's disease (CD) patients in the routine

vedolizumab
crohn's disease
  • 1 views
  • 15 Mar, 2022
  • 1 location
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

Vedolizumab is a medicine that helps to reduce sensitivity and pain in the digestive system for participants with UC or CD. In this study, adults with UC or CD will be treated with

ulcerative colitis
vedolizumab
crohn's disease
maintenance treatment
colitis
  • 0 views
  • 03 Dec, 2021
  • 6 locations
A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

or Crohn's disease when treated with vedolizumab. This will include how vedolizumab is given, which can either be an infusion through a vein (intravenous or IV), or an injection just under the skin

ulcerative colitis
crohn's disease
inflammatory bowel disease
ulcerative colitis or crohn's
vedolizumab
  • 0 views
  • 01 Jan, 2022
  • 1 location